威扬酒业控股(08509.HK)前三财季纯利跌34.82%至1247.5万港元
格隆汇2月12日丨威扬酒业控股(08509.HK)公布,截至2019年12月31日止9个月,公司实现收益2.20亿港元,同比增长0.02%;公司拥有人应占期间溢利1247.5万港元,同比减少34.82%;每股基本盈利3.12港仙;不派息。公告称,毛利及毛利率即收益减去销售成本。
于该期间,集团毛利2018年同期增加约12.1%至约4500万港元。截至2019年及2018年12月31日止九个月,整体毛利率分别增加及达至20.4%及18.2%。于该期间,集团录得相对较高的毛利率,此乃主要由于若干毛利率相对较高的大受追捧的顶级珍藏红酒的销售增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.